
Acurion Scales Leadership Team to Drive OncoGaze Platform Deployment
Following a $4.3 million seed funding round, San Diego-based precision oncology firm Acurion has significantly expanded its leadership, board, and advisory roster. The additions aim to bolster the company’s regulatory, clinical, and commercial capabilities as it prepares its AI-driven OncoGaze™ platform for clinical integration.



























